Skip to main content

and
Your search also matched 14 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient

Include preview-only content
  1. Article

    Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody

    JS-001 is the first monoclonal antibody (mAb) against programmed cell death protein-1 (PD-1) approved by the China Food and Drug Administration (CFDA) into the clinical trails. To date, however, no pre-clinica...

    Jie Fu, Fang Wang, Li-hou Dong, **g Zhang, Cheng-lian Deng in Acta Pharmacologica Sinica (2017)

  2. Article

    Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution

    Shenmai injection (SMI) is a Chinese patent-protected injection, which was mainly made of Red Ginseng and Radix Ophiopogonis and widely used for treating coronary heart disease and tumors by boosting Qi and no...

    Wen-yue Liu, **g-wei Zhang, Xue-quan Yao, Chao Jiang in Acta Pharmacologica Sinica (2017)

  3. Article

    Classification of 5-HT1A receptor agonists and antagonists using GA-SVM method

    To construct a reliable computational model for the classification of agonists and antagonists of 5-HT1A receptor.

    Xue-lian Zhu, Hai-yan Cai, Zhi-jian Xu, Yong Wang in Acta Pharmacologica Sinica (2011)